Optimisation-based modelling for explainable lead discovery in malaria

被引:2
作者
Li, Yutong [1 ]
Cardoso-Silva, Jonathan [2 ]
Kelly, John M. [3 ]
Delves, Michael J. [3 ]
Furnham, Nicholas [3 ]
Papageorgiou, Lazaros G. [4 ]
Tsoka, Sophia [1 ]
机构
[1] Kings Coll London, Dept Informat, Bush House, London WC2B 4BG, England
[2] London Sch Econ & Polit Sci, Data Sci Inst, Houghton St, London WC2A 2AE, England
[3] London Sch Hyg & Trop Med, Dept Infect Biol, Keppel St, London WC1E 7HT, England
[4] UCL, Sargent Ctr Proc Syst Engn, Dept Chem Engn, Torrington Pl, London WC1E 7JE, England
基金
英国工程与自然科学研究理事会; 英国医学研究理事会;
关键词
Quantitative Structure-Activity Relationship (QSAR); Mathematical optimisation; Piecewise linear regression; Drug discovery; Malaria; Machine learning; COMMUNITY STRUCTURE; DRUG DISCOVERY; ANTIMALARIAL; VALIDATION; MODULARITY; FALCIPARUM;
D O I
10.1016/j.artmed.2023.102700
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Background: The search for new antimalarial treatments is urgent due to growing resistance to existing therapies. The Open Source Malaria (OSM) project offers a promising starting point, having extensively screened various compounds for their effectiveness. Further analysis of the chemical space surrounding these compounds could provide the means for innovative drugs.Methods: We report an optimisation-based method for quantitative structure-activity relationship (QSAR) modelling that provides explainable modelling of ligand activity through a mathematical programming formulation. The methodology is based on piecewise regression principles and offers optimal detection of breakpoint features, efficient allocation of samples into distinct sub-groups based on breakpoint feature values, and insightful regression coefficients. Analysis of OSM antimalarial compounds yields interpretable results through rules generated by the model that reflect the contribution of individual fingerprint fragments in ligand activity prediction. Using knowledge of fragment prioritisation and screening of commercially available compound libraries, potential lead compounds for antimalarials are identified and evaluated experimentally via a Plasmodium falciparum asexual growth inhibition assay (PfGIA) and a human cell cytotoxicity assay.Conclusions: Three compounds are identified as potential leads for antimalarials using the methodology described above. This work illustrates how explainable predictive models based on mathematical optimisation can pave the way towards more efficient fragment-based lead discovery as applied in malaria
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Physiologically-based Pharmacokinetic Modelling for the Reduction of Animal Use in the Discovery of Novel Pharmaceuticals
    Thomas, Simon
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2010, 38 : 81 - 85
  • [32] Network Based Rule Representation for Knowledge Discovery and Predictive Modelling
    Liu, Han
    Gegov, Alexander
    Cocea, Mihaela
    2015 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE 2015), 2015,
  • [33] NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds
    Yu, Jun-lan
    Chen, Tian-tian
    Zhou, Chen
    Lian, Fu-lin
    Tang, Xu-long
    Wen, Yi
    Shen, Jing-kang
    Xu, Ye-chun
    Xiong, Bing
    Zhang, Nai-xia
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (07) : 984 - 993
  • [34] Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources
    Pinto Alberto, Anael Viana
    da Silva Ferreira, Natiele Carla
    Soares, Rafael Ferreira
    Alves, Luiz Anastacio
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [35] A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring
    Cramer, Jonathan
    Schiebel, Johannes
    Wulsdorf, Tobias
    Grohe, Kristof
    Najbauer, Eszter Eva
    Ehrmann, Frederik R.
    Radeva, Nedyalka
    Zitzer, Nina
    Linne, Uwe
    Linser, Rasmus
    Heine, Andreas
    Klebe, Gerhard
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (07) : 1908 - 1913
  • [36] BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery
    Kombarov, Roman
    Altieri, Andrea
    Genis, Dmitry
    Kirpichenok, Mikhail
    Kochubey, Valeriy
    Rakitina, Natalia
    Titarenko, Zoya
    MOLECULAR DIVERSITY, 2010, 14 (01) : 193 - 200
  • [37] Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery
    Zimmermann, Markus O.
    Lange, Andreas
    Wilcken, Rainer
    Cieslik, Markus B.
    Exner, Thomas E.
    Joerger, Andreas C.
    Koch, Pierre
    Boeckler, Frank M.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (06) : 617 - 639
  • [38] "Function-First" Lead Discovery: Mode of Action Profiling of Natural Product Libraries Using Image-Based Screening
    Schulze, Christopher J.
    Bray, Walter M.
    Woerhmann, Marcos H.
    Stuart, Joshua
    Lokey, R. Scott
    Linington, Roger G.
    CHEMISTRY & BIOLOGY, 2013, 20 (02): : 285 - 295
  • [39] Complementarity between in Silico and Biophysical Screening Approaches in Fragment-Based Lead Discovery against the A2A Adenosine Receptor
    Chen, Dan
    Ranganathan, Anirudh
    Ijzerman, Adriaan P.
    Siegal, Gregg
    Carlsson, Jens
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (10) : 2701 - 2714
  • [40] NMR approaches in structure-based lead discovery: Recent developments and new frontiers for targeting multi-protein complexes
    Dias, David M.
    Ciulli, Alessio
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2014, 116 (2-3) : 101 - 112